KLK6, KLK8 and KLK10 were measured in CSF of patients with clinical diagnosis of AD and evidence of the pathophysiological process, as assessed by a CSF biomarker profile and of a group of subjectively and objectively cognitively normal control subjects with normal AD CSF biomarkers. This evidence concerns the gene KLK10 and Alzheimer disease.